Drug intelligence / Profile preview

PRAISOLITE

Development stage: Unknown
Lead developer: Praise Pharmaceuticals
Modality: Small Molecules
Administration: Topical

Overview

**PRAISOLITE** is a marketed topical skin-whitening product family from Praise Pharma, available in distinct soap and gel presentations rather than as one compositionally uniform medicine. The official product pages identify skin-brightening formulations containing kojic acid dipalmitate, with the gel additionally listing arbutin and octinoxate; the manufacturer describes kojic acid as a skin-lightening agent and arbutin as an inhibitor of tyrosinase-mediated melanin formation. It is marketed for hyperpigmentation-related cosmetic and dermatologic concerns, including melasma. ([praisepharma.com](https://www.praisepharma.com/products/skin-whitening-agent_praisolite-soap.html))

Brand names: PRAISOLITE

Targets

TYR (Tyrosinase)

Beyond the preview

Go deeper on PRAISOLITE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRAISOLITE.

Explore the full profile